RRoche Read More Roche Stops Work on Obesity Drug Emugrobart After Trial Data2026-11-02 Roche Holding ROP -0.31%decrease; down pointing triangle said it stopped work on one of its obesity-drug candidates, after…
NNovartis Read More Novartis Stock Drops After Another Trial Setback2026-10-07 Novartis NOVN -1.46%decrease; down pointing triangle shares dropped as much as 10% after the drugmaker said an experimental…
RRoche Read More Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial2026-10-04 Roche ROP -1.72%decrease; down pointing triangle Holding said an obesity drug candidate met the main objectives of a…
NNovartis Read More Novartis Stock Prices Fall After Cardiovascular Drug Fails in Trial2026-09-23 Novartis NOVN 2.84%increase; up pointing triangle shares fell after the Swiss drugmaker said an experimental medicine failed to…
NNovartis Read More Novartis Stock Prices Rise After Positive Multiple Sclerosis Drug Trial Results2026-09-14 Novartis NOVN -0.09%decrease; down pointing triangle shares rose after the drugmaker reported positive results from two late-stage trials…
RRoche Read More Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial2026-08-13 Roche Holding ROP 1.21%increase; up pointing triangle said a drug candidate showed better potential than existing therapies in…
RRoche Read More Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study2026-05-30 Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
NNovartis Read More Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion2026-05-19 Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
NNovartis Read More Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion2026-04-03 Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…